Keep prescribing information private

March 01, 2004

Dick Zoutman and colleagues weigh in on the issue of protecting patient and physician prescription information and question the propriety of the practice of pharmacies selling such information to pharmaceutical companies.

The authors recommend a thorough review of the many issues associated with the confidentiality of personal health information.

Specifically, the authors call for a committee to be established by Health Canada to review and generate national standards on the issue and that the issue not be left in the hands of the pharmaceutical industry to review and manage.
-end-
Commentary
p. 815 The confidentiality of patient and physician information in pharmacy prescription records
-- D. E. Zoutman

Canadian Medical Association Journal

Related Pharmaceutical Companies Articles from Brightsurf:

Changes needed to prevent controversial pharmaceutical deals
New research from the University of East Anglia (UEA) recommends changes to the system which sees drug companies strike deals with competitors to stop them producing cheaper generic alternatives.

GARDP partners with Japanese pharmaceutical in pursuit of new antibiotics
The Global Antibiotic Research and Development Partnership (GARDP) has today announced an agreement with Daiichi Sankyo for GARDP to access and screen the Daiichi Sankyo chemical library.

Profits of large pharmaceutical companies compared to other large public companies
Data from annual financial reports were used to compare the profitability of 35 large pharmaceutical companies with 357 companies in the S&P 500 Index from 2000 to 2018.

New research reveals pharma companies are more profitable than most S&P 500 companies
Large pharmaceutical companies are more profitable than most companies in the S&P 500 according to a study published in the Journal of the American Medical Association.

The integrated catalysts can simplify pharmaceutical manufacturing
Prof. In Su Lee and his research team from POSTECH developed catalytic platforms based on metal organic frameworks.

Study: Pharmaceutical companies marketing stimulants to physicians
Results of a new study show that a large number of physicians in the US may have received marketing payments from pharmaceutical companies that produce stimulant medications.

3D printing with applications in the pharmaceutical industry
This achievement will have applications in the pharmaceutical industry, such as in the preparation of biocompatible biosensors based in gold, which have already been shown to be effective in the detection of carcinogenic cells and tumour biomarkers.

Turning wood into pharmaceutical ingredients 
Production of hazardous waste during drug manufacturing is a serious concern for the pharmaceutical industry.

New pharmaceutical target reverses osteoporosis in mice
Biomedical engineers at Duke University have discovered that an adenosine receptor called A2B can be pharmaceutically activated to reverse bone degradation caused by osteoporosis in mouse models of the disease.

Active pharmaceutical ingredients can persist in the environment
A study finds trace levels of medicines in drinking water from private wells.

Read More: Pharmaceutical Companies News and Pharmaceutical Companies Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.